speb/financial-data huggingface dataset:
Financial ratios for ALMKT.PA — annual report dated 2022-12-31
Total revenue: 7956382.978723405
Gross profit: 5823404.255319149
Operating income: -954255.3191489362
Net income: -11893617.021276597
Capital expenditures: 150000
Operating cash flow: -9393617.021276597
Depreciation & amortization: 1058510.6382978724
Net tangible assets: -24070212.76595745
Owner earnings: -10985106.382978724
Buffett classification: The Gruesome
Stock price: 0.43617021276595747
Shares outstanding: 194473901
Book value: -21196808.510638297
Market cap (USD): 84823722.77659574
Debt to equity: -1.4655457967377667
Current ratio: 1.1898894154818325
Quick ratio: 0.9398104265402843
Interest coverage ratio: -3.531496062992126
COGS to revenue (%): 26.808396844497924
R&D to revenue (%): 54.392298435619736
SG&A to revenue (%): 51.624548736462096
Free cash flow (dilution-adjusted): -9894680.85106383
Buyback yield (%): 0
Retained earnings: -11893617.021276597
Inventory turnover: 0.6332912192040429
Receivables turnover: 1.0352990033222593
Capitalized R&D asset: 4327659.574468086
ROCI (R&D-adjusted, %): 16.203910365145965
FCF margin (%): -124.36154566118465
Rule of 40 score: -124.36154566118465
Financial ratios for ALMKT.PA — annual report dated 2023-12-31
Total revenue: 11644444.444444444
Gross profit: 9290000
Operating income: -6320000
Net income: -4141111.111111111
Capital expenditures: 410000
Operating cash flow: -836666.6666666666
Depreciation & amortization: 1691111.111111111
Net tangible assets: -21433333.333333332
Owner earnings: -2860000
Buffett classification: The Gruesome
Stock price: 0.5222222222222221
Shares outstanding: 194473901
Book value: -19195555.55555556
Market cap (USD): 101558592.74444443
Debt to equity: -1.7233734660801108
Current ratio: 0.5357890800299177
Quick ratio: 0.4287210172026925
Interest coverage ratio: -21.066666666666666
COGS to revenue (%): 20.21946564885496
R&D to revenue (%): 36.832061068702295
SG&A to revenue (%): 39.87595419847328
Free cash flow (dilution-adjusted): -1386666.6666666665
Buyback yield (%): 0
Retained earnings: -4141111.111111111
Inventory turnover: 0.7401327279077891
Receivables turnover: 7.939393939393939
Capitalized R&D asset: 7188420.803782506
ROCI (R&D-adjusted, %): -165.4295897732852
Rosenberg metric: 0.8010324483775809
FCF margin (%): -11.908396946564885
Revenue growth (%): 46.353493485462984
Rule of 40 score: 34.4450965388981
Financial ratios for ALMKT.PA — annual report dated 2024-12-31
Total revenue: 7973958.333333334
Gross profit: 6708333.333333334
Operating income: -6301041.666666667
Net income: -10837500
Capital expenditures: 222916.6666666667
Operating cash flow: -6587500
Depreciation & amortization: 2062500
Net tangible assets: -26938541.666666668
Owner earnings: -8997916.666666666
Buffett classification: The Gruesome
Stock price: 0.17708333333333334
Shares outstanding: 194473901
Book value: -25405208.333333336
Market cap (USD): 34438086.63541667
Debt to equity: -1.309278773217434
Current ratio: 0.27083645518026794
Quick ratio: 0.14313543321245542
Interest coverage ratio: -13.236323851203501
COGS to revenue (%): 15.871979098628348
R&D to revenue (%): 46.374918354016984
SG&A to revenue (%): 41.93337687785761
Free cash flow (dilution-adjusted): -7383333.333333334
Buyback yield (%): 0
Retained earnings: -10837500
Inventory turnover: 0.28514433231635766
Receivables turnover: 5.746996996996997
Capitalized R&D asset: 7999599.881796692
Rosenberg metric: -0.601943005181347
FCF margin (%): -92.5930764206401
Revenue growth (%): -31.521350190839687
Rule of 40 score: -124.11442661147979
Financial ratios for ALMKT.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -26938541.666666668
Buffett classification: The Gruesome
Stock price: 0.17708333333333334
Shares outstanding: 194473901
Book value: -25405208.333333336
Market cap (USD): 34438086.63541667
Debt to equity: -1.309278773217434
Current ratio: 0.27083645518026794
Quick ratio: 0.14313543321245542
Buyback yield (%): 0
Retained earnings: -10837500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALS.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 110.09090909090908
Shares outstanding: 257420930
Market cap (USD): 28339704202.72727
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALS.DE — annual report dated 2022-12-31
Total revenue: 50617000000
Net income: -1289000000
Capital expenditures: 211000000
Operating cash flow: 5121000000
Depreciation & amortization: 847000000
Net tangible assets: 12809000000
Owner earnings: -653000000
Return on net tangible assets (%): -5.097977984229838
Buffett classification: The Gruesome
Stock price: 130.47872340425533
Shares outstanding: 257420930
Book value: 17363000000
P/B ratio: 1.9344557002785332
Market cap (USD): 33587954323.936172
Debt to equity: 0.4586764959972355
COGS to revenue (%): 0
SG&A to revenue (%): 0.22917201730643855
Free cash flow (dilution-adjusted): 4701000000
Buyback yield (%): 7.502689731253276
Retained earnings: 50970000000
Receivables turnover: 2.6946869676320273
Capitalized R&D asset: 0
FCF margin (%): 9.287393563427306
Rule of 40 score: 9.287393563427306
Financial ratios for ALS.DE — annual report dated 2023-12-31
Total revenue: 56591000000
Net income: -188000000
Capital expenditures: 240000000
Operating cash flow: 4228000000
Depreciation & amortization: 704000000
Net tangible assets: 13302000000
Owner earnings: 276000000
Buffett classification: The Gruesome
Stock price: 127.74444444444444
Shares outstanding: 257420930
Book value: 17630000000
P/B ratio: 1.8652350363710848
Market cap (USD): 32884093691.22222
Debt to equity: 0.450482132728304
COGS to revenue (%): 0
SG&A to revenue (%): 0.015903588909897334
Free cash flow (dilution-adjusted): 3961000000
Buyback yield (%): 2.7672953633595414
Retained earnings: 49716000000
Receivables turnover: 3.001697342597995
Capitalized R&D asset: 0
FCF margin (%): 6.99934618578926
Revenue growth (%): 11.802358891281585
Rule of 40 score: 18.801705077070846
Financial ratios for ALS.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 127.74444444444444
Shares outstanding: 257420930
Market cap (USD): 32884093691.22222
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALS.DE — annual report dated 2024-12-31
Total revenue: 63515000000
Net income: 4667000000
Capital expenditures: 192000000
Operating cash flow: 8931000000
Depreciation & amortization: 555000000
Net tangible assets: 17443000000
Owner earnings: 5030000000
Return on net tangible assets (%): 28.836782663532652
Buffett classification: The Gruesome
Stock price: 119.76041666666667
P/E ratio: 6.605707699918756
Shares outstanding: 257420930
Book value: 21367000000
P/B ratio: 1.4428248156278762
Market cap (USD): 30828837835.520836
Debt to equity: 0.3783872326484766
Effective tax rate (%): 20.17010935601458
COGS to revenue (%): 0
SG&A to revenue (%): -0.058253955758482245
Free cash flow (dilution-adjusted): 8721000000
Buyback yield (%): 0.006487432353663393
Retained earnings: 53288000000
Receivables turnover: 3.2508445081379875
Capitalized R&D asset: 0
FCF margin (%): 13.730614815397937
Revenue growth (%): 12.235161068014348
Rule of 40 score: 25.965775883412284
Financial ratios for ALS.DE — quarterly report dated 2024-12-31
Capital expenditures: 50000000
Buffett classification: The Gruesome
Stock price: 119.76041666666667
Shares outstanding: 257420930
Market cap (USD): 30828837835.520836
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALS.DE — quarterly report dated 2025-03-31
Total revenue: 16263000000
Net income: 596000000
Capital expenditures: 92000000
Operating cash flow: 1964000000
Depreciation & amortization: 132000000
Net tangible assets: 18940000000
Owner earnings: 636000000
Return on net tangible assets (%): 3.357972544878564
Buffett classification: The Gruesome
Stock price: 124.96739130434781
P/E ratio: 13.493801211929163
Shares outstanding: 257420930
Book value: 22052000000
P/B ratio: 1.4587893202085584
Market cap (USD): 32169222089.23913
Debt to equity: 0.36667875929620897
Effective tax rate (%): 17.10709318497914
COGS to revenue (%): 0
SG&A to revenue (%): 0.4796163069544364
Free cash flow (dilution-adjusted): 1872000000
Buyback yield (%): 0.30774757227690724
Retained earnings: 53586000000
Receivables turnover: 0.7691543700340522
Capitalized R&D asset: 0
FCF margin (%): 11.510791366906476
Rule of 40 score: 11.510791366906476
Financial ratios for ALS.DE — quarterly report dated 2025-06-30
Total revenue: 16546000000
Net income: 2109000000
Capital expenditures: 1000000
Operating cash flow: 1873000000
Depreciation & amortization: 127000000
Net tangible assets: 20901000000
Owner earnings: 2235000000
Return on net tangible assets (%): 10.69326826467633
Buffett classification: The Gruesome
Stock price: 135.25882352941176
P/E ratio: 12.871886189888007
Shares outstanding: 257420930
Book value: 24005000000
P/B ratio: 1.4504666587647181
Market cap (USD): 34818452143.64706
Debt to equity: 0.336888148302437
Effective tax rate (%): 22.345541990381058
COGS to revenue (%): 0
SG&A to revenue (%): 0
Free cash flow (dilution-adjusted): 1874000000
Buyback yield (%): 0.976493724067042
Retained earnings: 55400000000
Receivables turnover: 0.7910690380569899
Capitalized R&D asset: 0
FCF margin (%): 11.326000241750272
Revenue growth (%): 1.7401463444628913
Rule of 40 score: 13.066146586213163
Financial ratios for ALS.DE — quarterly report dated 2025-09-30
Total revenue: 17061000000
Net income: 3746000000
Capital expenditures: 48000000
Operating cash flow: 3284000000
Depreciation & amortization: 115000000
Net tangible assets: 24387000000
Owner earnings: 3813000000
Return on net tangible assets (%): 15.635379505474228
Buffett classification: The Gruesome
Stock price: 135.25882352941176
P/E ratio: 5.397372832684399
Shares outstanding: 257420930
Book value: 27489000000
P/B ratio: 1.2666321853704048
Market cap (USD): 34818452143.64706
Debt to equity: 0.2942631598093783
Effective tax rate (%): 22.30753268312928
COGS to revenue (%): 0
SG&A to revenue (%): -0.6330226833128186
Free cash flow (dilution-adjusted): 3236000000
Buyback yield (%): 1.0339345313651034
Retained earnings: 58853000000
Receivables turnover: 0.802341986455982
Capitalized R&D asset: 0
FCF margin (%): 18.96723521481742
Revenue growth (%): 3.1125347516015958
Rule of 40 score: 22.07976996641902
Financial ratios for ALS.DE — annual report dated 2025-12-31
Total revenue: 67069000000
Net income: 10282000000
Capital expenditures: 228000000
Operating cash flow: 10110000000
Depreciation & amortization: 482000000
Net tangible assets: 26934000000
Owner earnings: 10536000000
Return on net tangible assets (%): 39.117843617732234
Buffett classification: The Gruesome
Stock price: 206.60000000000002
P/E ratio: 5.1724532326395645
Shares outstanding: 257420930
Book value: 30589000000
P/B ratio: 1.738636900127497
Market cap (USD): 53183164138.00001
Debt to equity: 0.24485926313380627
Effective tax rate (%): 21.967163271511097
COGS to revenue (%): 0
SG&A to revenue (%): -0.05218506314392641
Free cash flow (dilution-adjusted): 9882000000
Buyback yield (%): 2.31840286298236
Retained earnings: 62393000000
Receivables turnover: 3.357647058823529
Capitalized R&D asset: 0
FCF margin (%): 14.734079828236593
Revenue growth (%): 5.595528615287727
Rule of 40 score: 20.32960844352432
Financial ratios for ALS.DE — quarterly report dated 2025-12-31
Total revenue: 17199000000
Net income: 3832000000
Capital expenditures: 89000000
Operating cash flow: 2989000000
Depreciation & amortization: 108000000
Net tangible assets: 26934000000
Owner earnings: 3851000000
Return on net tangible assets (%): 14.297913417984704
Buffett classification: The Gruesome
Stock price: 206.60000000000002
P/E ratio: 5.171950222503161
Shares outstanding: 257420930
Book value: 30589000000
P/B ratio: 1.738636900127497
Market cap (USD): 53183164138.00001
Debt to equity: 0.24485926313380627
Effective tax rate (%): 22.136317395727364
COGS to revenue (%): 0
SG&A to revenue (%): -0.02907145764288621
Free cash flow (dilution-adjusted): 2900000000
Buyback yield (%): 0.8160477230611064
Retained earnings: 62393000000
Receivables turnover: 0.861026282853567
Capitalized R&D asset: 0
FCF margin (%): 16.861445432874003
Revenue growth (%): 0.8088623175663794
Rule of 40 score: 17.670307750440383
Financial ratios for AML.V — annual report dated 2021-12-31
Total revenue: 0
Gross profit: -467.7165354330709
Operating income: -138722.8346456693
Net income: -168796.8503937008
Capital expenditures: 2282.6771653543306
Operating cash flow: -135113.38582677164
Depreciation & amortization: 467.7165354330709
Net tangible assets: 2806625.1968503934
Owner earnings: -170611.81102362205
Return on net tangible assets (%): -6.078895436949805
Buffett classification: The Gruesome
Stock price: 0.15748031496062992
Shares outstanding: 14623092
Book value: 2806625.196850394
P/B ratio: 0.820504688849275
Market cap (USD): 2302849.1338582677
Debt to equity: 0.12493105458569065
Current ratio: 0.5541872498226167
Quick ratio: 0.5541872498226167
Interest coverage ratio: -4.670059642147117
Free cash flow (dilution-adjusted): -137396.06299212598
Buyback yield (%): 0
Retained earnings: -14564948.031496063
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.9426918421934145
Rule of 40 score: 0
Financial ratios for AML.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -638.970588235294
Operating income: -130747.79411764705
Net income: -123658.08823529411
Capital expenditures: 0
Operating cash flow: -120257.35294117646
Depreciation & amortization: 638.970588235294
Net tangible assets: 3005349.264705882
Owner earnings: -123019.11764705881
Return on net tangible assets (%): -4.093338471230832
Buffett classification: The Gruesome
Stock price: 0.2205882352941176
Shares outstanding: 14623092
Book value: 3005349.264705882
P/B ratio: 1.073313540194873
Market cap (USD): 3225682.0588235287
Debt to equity: 0.005094103039311033
Current ratio: 0.39045138040130467
Quick ratio: 0.39045138040130467
Interest coverage ratio: -18.802685841175848
Free cash flow (dilution-adjusted): -120257.35294117646
Buyback yield (%): 0
Retained earnings: -13724749.264705881
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.350502474142308
Rule of 40 score: 0
Financial ratios for AML.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -657.5757575757575
Operating income: -154715.9090909091
Net income: -156061.36363636362
Capital expenditures: 159977.2727272727
Operating cash flow: -146062.12121212122
Depreciation & amortization: 657.5757575757575
Net tangible assets: 3015869.696969697
Owner earnings: -315381.06060606055
Return on net tangible assets (%): -10.45738351769478
Buffett classification: The Gruesome
Stock price: 0.10606060606060606
Shares outstanding: 14623092
Book value: 3015869.696969697
P/B ratio: 0.5142576290873431
Market cap (USD): 1550934
Debt to equity: 0.058346906314777285
Current ratio: 0.21086676974817914
Quick ratio: 0.21086676974817914
Interest coverage ratio: -122.58403361344538
Free cash flow (dilution-adjusted): -306039.3939393939
Buyback yield (%): 0
Retained earnings: -14296712.121212121
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.130059473271191
Rule of 40 score: 0
Financial ratios for AML.V — quarterly report dated 2024-09-30
Gross profit: -160.74074074074073
Capital expenditures: 10740.74074074074
Depreciation & amortization: 160.74074074074073
Buffett classification: The Gruesome
Stock price: 0.11851851851851851
Shares outstanding: 14623092
Market cap (USD): 1733107.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AML.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -508.39160839160843
Operating income: -125561.53846153847
Net income: -126454.54545454546
Capital expenditures: 3344.055944055944
Operating cash flow: -154121.67832167834
Depreciation & amortization: 508.39160839160843
Net tangible assets: 2965241.2587412586
Owner earnings: -129290.20979020979
Return on net tangible assets (%): -4.360191920609298
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 14623092
Book value: 2965241.258741259
P/B ratio: 0.41383230176202357
Market cap (USD): 1227112.6153846155
Debt to equity: 0.08790237471685342
Current ratio: 0.20854381153621365
Quick ratio: 0.20854381153621365
Interest coverage ratio: -141.49172576832152
Free cash flow (dilution-adjusted): -157465.73426573427
Buyback yield (%): 0
Retained earnings: -13323419.580419581
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.234445952463213
Rule of 40 score: 0
Financial ratios for AML.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -53.14685314685315
Operating income: -32967.13286713287
Net income: -32900
Capital expenditures: 26100
Operating cash flow: -47751.74825174826
Depreciation & amortization: 53.14685314685315
Net tangible assets: 2965241.2587412586
Owner earnings: -58946.853146853144
Return on net tangible assets (%): -1.9879277267265603
Buffett classification: The Gruesome
Stock price: 0.08391608391608392
Shares outstanding: 14623092
Book value: 2965241.258741259
P/B ratio: 0.41383230176202357
Market cap (USD): 1227112.6153846155
Debt to equity: 0.08790237471685342
Current ratio: 0.20854381153621365
Quick ratio: 0.20854381153621365
Free cash flow (dilution-adjusted): -21651.748251748253
Buyback yield (%): 0
Retained earnings: -13323419.580419581
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.111785854521914
Rule of 40 score: 0
Financial ratios for AML.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: 0
Operating income: -27160.83916083916
Net income: -27112.587412587414
Capital expenditures: 4349.65034965035
Operating cash flow: -37739.16083916084
Depreciation & amortization: 0
Net tangible assets: 3208495.8041958045
Owner earnings: -31462.237762237764
Return on net tangible assets (%): -0.9805915195866568
Buffett classification: The Gruesome
Stock price: 0.06993006993006994
Shares outstanding: 14623092
Book value: 3208495.8041958045
P/B ratio: 0.31871440966716647
Market cap (USD): 1022593.8461538462
Debt to equity: 0.024668117796523174
Current ratio: 0.6797243543442876
Quick ratio: 0.6797243543442876
Free cash flow (dilution-adjusted): -42088.81118881119
Buyback yield (%): 0
Retained earnings: -13350532.167832168
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8465287417649252
Rule of 40 score: 0
Financial ratios for AML.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: 0
Operating income: -39479.56204379562
Net income: -39537.22627737226
Capital expenditures: 61.31386861313868
Operating cash flow: -44124.087591240874
Depreciation & amortization: 0
Net tangible assets: 3150622.627737226
Owner earnings: -39598.5401459854
Return on net tangible assets (%): -1.2568480844824323
Buffett classification: The Gruesome
Stock price: 0.0875912408759124
Shares outstanding: 14623092
Book value: 3150622.627737226
P/B ratio: 0.4065402065123033
Market cap (USD): 1280854.7737226277
Debt to equity: 0.025155032500817243
Current ratio: 0.4517968320049119
Quick ratio: 0.4517968320049119
Free cash flow (dilution-adjusted): -44062.77372262773
Buyback yield (%): 0
Retained earnings: -13974764.23357664
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.2530717483023284
Rule of 40 score: 0
Financial ratios for AML.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: 0
Operating income: -15971.942446043167
Net income: -15964.74820143885
Capital expenditures: 20.863309352517987
Operating cash flow: -19630.215827338132
Depreciation & amortization: 0
Net tangible assets: 3142499.28057554
Owner earnings: -15985.611510791368
Return on net tangible assets (%): -0.5086910157657585
Buffett classification: The Gruesome
Stock price: 0.07194244604316548
Shares outstanding: 14623092
Book value: 3142499.2805755395
P/B ratio: 0.33477207574780105
Market cap (USD): 1052021.0071942448
Debt to equity: 0.025215003225677955
Current ratio: 0.342357402046724
Quick ratio: 0.342357402046724
Free cash flow (dilution-adjusted): -19651.07913669065
Buyback yield (%): 0
Retained earnings: -13789653.237410072
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5082560414498473
Rule of 40 score: 0
Financial ratios for AML.V — annual report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0875912408759124
Shares outstanding: 14623092
Market cap (USD): 1280854.7737226277
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AML.V — quarterly report dated 2025-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0875912408759124
Shares outstanding: 14623092
Market cap (USD): 1280854.7737226277
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARAY — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.52
Shares outstanding: 118963696
Market cap (USD): 537715905.92
Buyback yield (%): 2.618483077213414
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARAY — annual report dated 2022-06-30
Total revenue: 429909000
Gross profit: 159955000
Operating income: 8148000
Net income: -5347000
Capital expenditures: 4717000
Operating cash flow: -2400000
Depreciation & amortization: 5513000
Net tangible assets: -4901000
Owner earnings: -4551000
Capex to operating income (%): 57.891507118311246
Buffett classification: The Good
Stock price: 1.96
Shares outstanding: 118963696
Book value: 53189000
P/B ratio: 4.383779431085375
Market cap (USD): 233168844.16
Debt to equity: 3.750587527496287
Current ratio: 1.6800409847839202
Quick ratio: 0.9989370768656216
Interest coverage ratio: 1.0023373108623448
COGS to revenue (%): 62.793288812283535
R&D to revenue (%): 13.433540586496212
SG&A to revenue (%): 21.87788578513127
Free cash flow (dilution-adjusted): -17717000
Buyback yield (%): 0
Retained earnings: -492522000
Inventory turnover: 1.8976900473800384
Receivables turnover: 4.235556650246306
Capitalized R&D asset: 57752000
ROCI (R&D-adjusted, %): 14.498942737940942
FCF margin (%): -4.121104698901395
Rule of 40 score: -4.121104698901395
Financial ratios for ARAY — annual report dated 2023-06-30
Total revenue: 447605000
Gross profit: 153960000
Operating income: 2382000
Net income: -9280000
Capital expenditures: 12614000
Operating cash flow: 15539000
Depreciation & amortization: 4527000
Net tangible assets: -4232000
Owner earnings: -17367000
Capex to operating income (%): 529.5549958018472
Buffett classification: The Gruesome
Stock price: 3.87
Shares outstanding: 118963696
Book value: 53659000
P/B ratio: 8.57991210272275
Market cap (USD): 460389503.52000004
Debt to equity: 3.821092454201532
Current ratio: 1.7017625115159813
Quick ratio: 0.9710325870809567
Interest coverage ratio: 0.22404063205417607
COGS to revenue (%): 65.60360138961808
R&D to revenue (%): 12.763262251315332
SG&A to revenue (%): 21.10097072195351
Free cash flow (dilution-adjusted): -7195000
Buyback yield (%): 0
Retained earnings: -502136000
Inventory turnover: 2.0230451257320015
Receivables turnover: 5.127498711266395
Capitalized R&D asset: 95822840
ROCI (R&D-adjusted, %): 5.636913483633079
Rosenberg metric: -0.10380592879900263
FCF margin (%): -1.6074440634041176
Revenue growth (%): 4.116219944220754
Rule of 40 score: 2.5087758808166365
Financial ratios for ARAY — annual report dated 2024-06-30
Total revenue: 446551000
Gross profit: 142921000
Operating income: 504000
Net income: -15545000
Capital expenditures: 3601000
Operating cash flow: -11904000
Depreciation & amortization: 5905000
Net tangible assets: -12647000
Owner earnings: -13241000
Capex to operating income (%): 714.484126984127
Buffett classification: The Gruesome
Stock price: 1.82
Shares outstanding: 118963696
Book value: 45084000
P/B ratio: 4.80245600922722
Market cap (USD): 216513926.72
Debt to equity: 4.674540857066809
Current ratio: 1.6553539512564848
Quick ratio: 0.9469700461419492
Interest coverage ratio: 0.043358568479008944
COGS to revenue (%): 67.99447319567082
R&D to revenue (%): 11.13691381275599
SG&A to revenue (%): 20.755747943683925
Free cash flow (dilution-adjusted): -24989000
Buyback yield (%): 0
Retained earnings: -517681000
Inventory turnover: 2.1950637633382493
Receivables turnover: 4.517232309948915
Capitalized R&D asset: 107066590
ROCI (R&D-adjusted, %): -1.2183690945472554
Rosenberg metric: -0.19322935811934394
FCF margin (%): -5.596001352589066
Revenue growth (%): -0.23547547502820568
Rule of 40 score: -5.831476827617271
Financial ratios for ARAY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8
Shares outstanding: 118963696
Market cap (USD): 214134652.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARAY — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.98
Shares outstanding: 118963696
Market cap (USD): 235548118.07999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARAY — quarterly report dated 2025-03-31
Total revenue: 113243000
Gross profit: 31627000
Operating income: 1047000
Net income: -1297000
Capital expenditures: 958000
Operating cash flow: 18061000
Depreciation & amortization: 1575000
Net tangible assets: -8163000
Owner earnings: -680000
Capex to operating income (%): 91.49952244508118
Buffett classification: The Gruesome
Stock price: 1.79
Shares outstanding: 118963696
Book value: 49583000
P/B ratio: 4.294718267148014
Market cap (USD): 212945015.84
Debt to equity: 4.323417300284372
Current ratio: 1.6391861533999577
Quick ratio: 0.9193035407931023
Interest coverage ratio: 0.36228373702422145
COGS to revenue (%): 72.07156292221153
R&D to revenue (%): 9.459304327861325
SG&A to revenue (%): 17.544572291444062
Free cash flow (dilution-adjusted): 12885000
Buyback yield (%): 0
Retained earnings: -520395000
Inventory turnover: 0.5573150329475229
Receivables turnover: 1.2726506484457532
Capitalized R&D asset: 10712000
ROCI (R&D-adjusted, %): 2.808320815070388
FCF margin (%): 11.378186731188682
Rule of 40 score: 11.378186731188682
Financial ratios for ARAY — annual report dated 2025-06-30
Total revenue: 458505000
Gross profit: 146967000
Operating income: 7839000
Net income: -1591000
Capital expenditures: 4272000
Operating cash flow: 2860000
Depreciation & amortization: 6150000
Net tangible assets: 23352000
Owner earnings: 287000
Capex to operating income (%): 54.49674703406047
Buffett classification: The Good
Stock price: 1.37
Shares outstanding: 118963696
Book value: 81169000
P/B ratio: 2.007912670108046
Market cap (USD): 162980263.52
Debt to equity: 2.17296012024295
Current ratio: 1.6484923070532094
Quick ratio: 0.916221394856137
Effective tax rate (%): 240.29982363315696
Interest coverage ratio: 0.6051412691060676
COGS to revenue (%): 67.94647822815455
R&D to revenue (%): 10.456156421413072
SG&A to revenue (%): 19.887678433168666
Free cash flow (dilution-adjusted): -15864000
Buyback yield (%): 0
Retained earnings: -519272000
Inventory turnover: 2.2091760034037726
Receivables turnover: 4.684980636986931
Capitalized R&D asset: 100115010
ROCI (R&D-adjusted, %): 1.1064786948189083
Rosenberg metric: 0.08135606852730637
FCF margin (%): -3.4599404586645734
Revenue growth (%): 2.6769618699767777
Rule of 40 score: -0.7829785886877958
Financial ratios for ARAY — quarterly report dated 2025-06-30
Total revenue: 127543000
Gross profit: 38979000
Operating income: 4234000
Net income: 1123000
Capital expenditures: 1320000
Operating cash flow: -9708000
Depreciation & amortization: 1598000
Net tangible assets: 23352000
Owner earnings: 1401000
Return on net tangible assets (%): 5.999486125385406
Capex to operating income (%): 31.17619272555503
Buffett classification: The Good
Stock price: 1.37
P/E ratio: 36.28233827248442
Shares outstanding: 118963696
Book value: 81169000
P/B ratio: 2.007912670108046
Market cap (USD): 162980263.52
Debt to equity: 2.17296012024295
Current ratio: 1.6484923070532094
Quick ratio: 0.916221394856137
Effective tax rate (%): 45.77498792853694
Interest coverage ratio: 1.0018930430667297
COGS to revenue (%): 69.43854229553953
R&D to revenue (%): 8.993045482699952
SG&A to revenue (%): 18.24874748124162
Free cash flow (dilution-adjusted): -15929000
Buyback yield (%): 0
Retained earnings: -519272000
Inventory turnover: 0.6280243937030209
Receivables turnover: 1.3032278500413828
Capitalized R&D asset: 18647040
ROCI (R&D-adjusted, %): 2.804523307984853
Rosenberg metric: 0.6863330843913368
FCF margin (%): -12.489121315948347
Revenue growth (%): 12.627712088164389
Rule of 40 score: 0.1385907722160411
Financial ratios for ARAY — quarterly report dated 2025-09-30
Total revenue: 93942000
Gross profit: 26548000
Operating income: -11313000
Net income: -21678000
Capital expenditures: 1904000
Operating cash flow: 12180000
Depreciation & amortization: 1676000
Net tangible assets: 4043000
Owner earnings: -21906000
Return on net tangible assets (%): -541.8253771951521
Buffett classification: The Gruesome
Stock price: 1.67
Shares outstanding: 118963696
Book value: 61867000
P/B ratio: 3.2112333282687056
Market cap (USD): 198669372.32
Debt to equity: 2.8951298753778265
Current ratio: 1.5600425461944794
Quick ratio: 0.7610013770990484
Interest coverage ratio: -1.4049925484351713
COGS to revenue (%): 71.7400097932767
R&D to revenue (%): 12.102148133954993
SG&A to revenue (%): 28.200378957228928
Free cash flow (dilution-adjusted): 5841000
Buyback yield (%): 0
Retained earnings: -540950000
Inventory turnover: 0.43339356796974976
Receivables turnover: 1.536054154812126
Capitalized R&D asset: 22588860
ROCI (R&D-adjusted, %): -3.9072842860831085
Rosenberg metric: -1.0837837837837838
FCF margin (%): 6.217666219582296
Revenue growth (%): -26.34484056357464
Rule of 40 score: -20.127174343992344
Financial ratios for ARAY — quarterly report dated 2025-12-31
Total revenue: 102241000
Gross profit: 24072000
Operating income: -5491000
Net income: -13770000
Capital expenditures: 3025000
Operating cash flow: -15986000
Depreciation & amortization: 2163000
Net tangible assets: -4430000
Owner earnings: -14632000
Buffett classification: The Gruesome
Stock price: 0.82
Shares outstanding: 118963696
Book value: 53420000
P/B ratio: 1.8260994144515164
Market cap (USD): 97550230.72
Debt to equity: 3.261437663796331
Current ratio: 1.4660522766359638
Quick ratio: 0.7091190790166417
Interest coverage ratio: -0.7122843429757426
COGS to revenue (%): 76.45562934634833
R&D to revenue (%): 10.416564783208301
SG&A to revenue (%): 18.498449741297524
Free cash flow (dilution-adjusted): -22464000
Buyback yield (%): 0
Retained earnings: -554720000
Inventory turnover: 0.5178058054344802
Receivables turnover: 1.296799888382948
Capitalized R&D asset: 22052330
ROCI (R&D-adjusted, %): -2.218590018052095
Rosenberg metric: -0.2177852053830592
FCF margin (%): -21.97161608356726
Revenue growth (%): 8.834174277745843
Rule of 40 score: -13.137441805821416
Financial ratios for ARU.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.09774436090225563
Shares outstanding: 6070602115
Market cap (USD): 593367124.0225563
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ARU.AX — annual report dated 2022-06-30
Operating income: -24632129.655172415
Net income: -24522910.34482759
Capital expenditures: 87068.27586206897
Depreciation & amortization: 219702.75862068965
Net tangible assets: 91288326.89655173
Owner earnings: -24390275.862068966
Return on net tangible assets (%): -26.717847386674222
Buffett classification: The Gruesome
Stock price: 0.1931034482758621
Shares outstanding: 6070602115
Book value: 91288326.89655173
P/B ratio: 12.841227803918944
Market cap (USD): 1172254201.5172415
Debt to equity: 0.003582555715058602
Current ratio: 2.368484676418333
Quick ratio: 2.368484676418333
Interest coverage ratio: -3034.0288820931023
Free cash flow (dilution-adjusted): -21697219.310344826
Buyback yield (%): 0.11692921078319005
Retained earnings: -116204018.62068966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.938490233049855
Rule of 40 score: 0
Financial ratios for ARU.AX — annual report dated 2023-06-30
Operating income: -65992562.25165563
Net income: -63827658.27814569
Capital expenditures: 184829.13907284767
Depreciation & amortization: 382139.0728476821
Net tangible assets: 142319012.58278146
Owner earnings: -63630348.344370864
Return on net tangible assets (%): -44.709661196784616
Buffett classification: The Gruesome
Stock price: 0.2052980132450331
Shares outstanding: 6070602115
Book value: 142319012.58278146
P/B ratio: 8.756964588169003
Market cap (USD): 1246282553.410596
Debt to equity: 0.007611368041749729
Current ratio: 3.2198829322019553
Quick ratio: 3.2198829322019553
Interest coverage ratio: -5679.6106583072105
Free cash flow (dilution-adjusted): -47480694.0397351
Buyback yield (%): 0.35568002886380423
Retained earnings: -175414298.6754967
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -45.44566802710133
Rule of 40 score: 0
Financial ratios for ARU.AX — annual report dated 2024-06-30
Operating income: -68374275.33333333
Net income: -67316288
Capital expenditures: 66052
Depreciation & amortization: 5607655.333333333
Net tangible assets: 96076202
Owner earnings: -61774684.666666664
Return on net tangible assets (%): -64.29759230768371
Buffett classification: The Gruesome
Stock price: 0.11333333333333334
Shares outstanding: 6070602115
Book value: 96076202
P/B ratio: 7.160998860397639
Market cap (USD): 688001573.0333334
Debt to equity: 0.005200948028038549
Current ratio: 1.8865561094690968
Quick ratio: 1.8865561094690968
Interest coverage ratio: -1667.1772977014857
Free cash flow (dilution-adjusted): -74706526.66666667
Buyback yield (%): 0.15294373945891426
Retained earnings: -243900015.33333334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -69.56356558607595
Rule of 40 score: 0
Financial ratios for AVAV — annual report dated 2022-04-30
Total revenue: 445732000
Gross profit: 141236000
Operating income: -9887000
Net income: -4185000
Capital expenditures: 22289000
Operating cash flow: -9618000
Depreciation & amortization: 60825000
Net tangible assets: 176398000
Owner earnings: 34351000
Buffett classification: The Gruesome
Stock price: 80.32
Shares outstanding: 50608030
Book value: 608210000
P/B ratio: 6.683278751746929
Market cap (USD): 4064836969.5999994
Debt to equity: 0.356084247217244
Current ratio: 3.6384787604422484
Quick ratio: 2.7446223037547712
Interest coverage ratio: -1.8174632352941176
COGS to revenue (%): 68.31369522493337
R&D to revenue (%): 12.269480315525922
SG&A to revenue (%): 21.63497348182316
Free cash flow (dilution-adjusted): -37297000
Buyback yield (%): 0
Retained earnings: 347233000
Inventory turnover: 3.359807567114279
Receivables turnover: 2.704585998082594
Capitalized R&D asset: 54689000
ROCI (R&D-adjusted, %): 3.0631002415375406
FCF margin (%): -8.367584108836699
Rule of 40 score: -8.367584108836699
Financial ratios for AVAV — annual report dated 2023-04-30
Total revenue: 540536000
Gross profit: 173514000
Operating income: -22646000
Net income: -176167000
Capital expenditures: 14868000
Operating cash flow: 11400000
Depreciation & amortization: 99999000
Net tangible assets: 326592000
Owner earnings: -91036000
Return on net tangible assets (%): -27.87453458749755
Buffett classification: The Gruesome
Stock price: 100.69
Shares outstanding: 50608030
Book value: 550970000
P/B ratio: 9.248638838230757
Market cap (USD): 5095722540.7
Debt to equity: 0.2955188122765305
Current ratio: 3.9313135642111856
Quick ratio: 2.7872484217119684
Interest coverage ratio: -2.417378309137489
COGS to revenue (%): 67.89964035697899
R&D to revenue (%): 11.887274853108766
SG&A to revenue (%): 24.40262998209185
Free cash flow (dilution-adjusted): -14233000
Buyback yield (%): 0
Retained earnings: 171021000
Inventory turnover: 2.643984036192315
Receivables turnover: 2.796560537234978
Capitalized R&D asset: 100896630
ROCI (R&D-adjusted, %): 0.2438631211348208
Rosenberg metric: 0.5902100970944797
FCF margin (%): -2.6331271182677933
Revenue growth (%): 21.269282887474986
Rule of 40 score: 18.636155769207193
Financial ratios for AVAV — annual report dated 2024-04-30
Total revenue: 716720000
Gross profit: 283931000
Operating income: 71824000
Net income: 59666000
Capital expenditures: 22983000
Operating cash flow: 15292000
Depreciation & amortization: 35749000
Net tangible assets: 474869000
Owner earnings: 72432000
Return on net tangible assets (%): 15.253048735546013
Capex to operating income (%): 31.999053241256405
Buffett classification: The Good
Stock price: 159.79
P/E ratio: 135.53208047631816
Shares outstanding: 50608030
Book value: 822745000
P/B ratio: 9.82887421217996
Market cap (USD): 8086657113.7
Debt to equity: 0.07253523266625747
Current ratio: 3.5587007088674
Quick ratio: 2.522194382898833
Effective tax rate (%): 2.99062168872863
Interest coverage ratio: 17.019905213270142
COGS to revenue (%): 60.384669047884806
R&D to revenue (%): 13.629729880567027
SG&A to revenue (%): 15.964393347471816
Free cash flow (dilution-adjusted): -26260000
Buyback yield (%): 0
Retained earnings: 230687000
Inventory turnover: 2.882032124021096
Receivables turnover: 2.6566930709951477
Capitalized R&D asset: 158785220
ROCI (R&D-adjusted, %): 9.44881127161723
Rosenberg metric: 1.718418800093378
FCF margin (%): -3.663913383190088
Revenue growth (%): 32.59431379223586
Rule of 40 score: 28.93040040904577
Financial ratios for AVAV — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 214.96
Shares outstanding: 50608030
Market cap (USD): 10878702128.800001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVAV — quarterly report dated 2025-01-31
Total revenue: 167636000
Gross profit: 63199000
Operating income: -3087000
Net income: -1754000
Capital expenditures: 3845000
Operating cash flow: -25763000
Depreciation & amortization: 9290000
Net tangible assets: 527986000
Owner earnings: 3691000
Buffett classification: The Gruesome
Stock price: 180.15
Shares outstanding: 50608030
Book value: 861055000
P/B ratio: 10.588216321257063
Market cap (USD): 9117036604.5
Debt to equity: 0.06873544663232894
Current ratio: 4.2191795699258385
Quick ratio: 3.0712833959102617
Interest coverage ratio: -12.44758064516129
COGS to revenue (%): 62.29986399102818
R&D to revenue (%): 13.420744947386003
SG&A to revenue (%): 26.120880956357823
Free cash flow (dilution-adjusted): -34989000
Buyback yield (%): 0
Retained earnings: 257642000
Inventory turnover: 0.7057841633270935
Receivables turnover: 0.5142303232574833
Capitalized R&D asset: 22498000
ROCI (R&D-adjusted, %): 1.2648666518712488
FCF margin (%): -20.87200839915054
Rule of 40 score: -20.87200839915054
Financial ratios for AVAV — quarterly report dated 2025-04-30
Total revenue: 275050000
Gross profit: 100332000
Operating income: 32176000
Net income: 16664000
Capital expenditures: 8524000
Operating cash flow: -264000
Depreciation & amortization: 13854000
Net tangible assets: 581015000
Owner earnings: 21994000
Return on net tangible assets (%): 3.7854444377511767
Capex to operating income (%): 26.491795126802586
Buffett classification: The Good
Stock price: 151.52
P/E ratio: 115.04033703792608
Shares outstanding: 50608030
Book value: 886507000
P/B ratio: 8.64982307595992
Market cap (USD): 7668128705.6
Debt to equity: 0.07252170597637694
Current ratio: 3.5229581612560334
Quick ratio: 2.6860090264345584
Effective tax rate (%): 1.7016405951926745
Interest coverage ratio: 31.82591493570722
COGS to revenue (%): 63.5222686784221
R&D to revenue (%): 9.05362661334303
SG&A to revenue (%): 15.725868023995638
Free cash flow (dilution-adjusted): -14731000
Buyback yield (%): 0
Retained earnings: 274306000
Inventory turnover: 1.2125615934485392
Receivables turnover: 0.7005894069760926
Capitalized R&D asset: 39975660
ROCI (R&D-adjusted, %): 4.17632192811024
Rosenberg metric: 1.6505022668681661
FCF margin (%): -5.355753499363752
Revenue growth (%): 64.07573552220288
Rule of 40 score: 58.719982022839126
Financial ratios for AVAV — annual report dated 2025-04-30
Total revenue: 820627000
Gross profit: 318636000
Operating income: 59154000
Net income: 43619000
Capital expenditures: 19547000
Operating cash flow: -1318000
Depreciation & amortization: 40998000
Net tangible assets: 581015000
Owner earnings: 65070000
Return on net tangible assets (%): 11.199366625646498
Capex to operating income (%): 33.044257362139504
Buffett classification: The Good
Stock price: 151.52
P/E ratio: 175.79790241867076
Shares outstanding: 50608030
Book value: 886507000
P/B ratio: 8.64982307595992
Market cap (USD): 7668128705.6
Debt to equity: 0.07252170597637694
Current ratio: 3.5229581612560334
Quick ratio: 2.6860090264345584
Effective tax rate (%): 2.2236789027833805
Interest coverage ratio: 27.03564899451554
COGS to revenue (%): 61.17164070887261
R&D to revenue (%): 12.27463878229695
SG&A to revenue (%): 19.345329851442862
Free cash flow (dilution-adjusted): -45595000
Buyback yield (%): 0
Retained earnings: 274306000
Inventory turnover: 3.483871191616351
Receivables turnover: 2.090247530552881
Capitalized R&D asset: 187383440
ROCI (R&D-adjusted, %): 6.3679056568795005
Rosenberg metric: 0.3552673334220521
FCF margin (%): -5.55611745653019
Revenue growth (%): 14.497572273691262
Rule of 40 score: 8.941454817161071
Financial ratios for AVAV — quarterly report dated 2025-07-31
Total revenue: 454676000
Gross profit: 95118000
Operating income: -69272000
Net income: -67370000
Capital expenditures: 22728000
Operating cash flow: -123726000
Depreciation & amortization: 90254000
Net tangible assets: 768671000
Owner earnings: 156000
Buffett classification: The Gruesome
Stock price: 267.64
Shares outstanding: 50608030
Book value: 4427079000
P/B ratio: 3.0595191884310173
Market cap (USD): 13544733149.199999
Debt to equity: 0.18741657874187473
Current ratio: 5.962750518313753
Quick ratio: 5.115669443130979
Interest coverage ratio: -3.9777203560149297
COGS to revenue (%): 79.08004821015405
R&D to revenue (%): 7.282988325752844
SG&A to revenue (%): 28.872427838724718
Free cash flow (dilution-adjusted): -167223000
Buyback yield (%): 0
Retained earnings: 206936000
Inventory turnover: 1.5439095187386211
Receivables turnover: 0.6657617568721164
Capitalized R&D asset: 57222680
ROCI (R&D-adjusted, %): -1.1652267569446486
Rosenberg metric: -0.20938077262870453
FCF margin (%): -36.77849721559968
Revenue growth (%): 65.30667151427014
Rule of 40 score: 28.528174298670457
Financial ratios for AVAV — quarterly report dated 2025-10-31
Total revenue: 472508000
Gross profit: 104105000
Operating income: -30224000
Net income: -17103000
Capital expenditures: 10809000
Operating cash flow: -45084000
Depreciation & amortization: 58073000
Net tangible assets: 822625000
Owner earnings: 30161000
Buffett classification: The Gruesome
Stock price: 369.91
Shares outstanding: 50608030
Book value: 4418081000
P/B ratio: 4.237227967821323
Market cap (USD): 18720416377.300003
Debt to equity: 0.18694428644472566
Current ratio: 5.080243394598615
Quick ratio: 4.290024906486356
COGS to revenue (%): 77.96756880306789
R&D to revenue (%): 7.617437165085035
SG&A to revenue (%): 20.81149948783936
Free cash flow (dilution-adjusted): -68385000
Buyback yield (%): 0
Retained earnings: 189833000
Inventory turnover: 1.4212365892142755
Receivables turnover: 0.611839839228046
Capitalized R&D asset: 66397040
ROCI (R&D-adjusted, %): -0.47550888930087837
Rosenberg metric: 0.27139578426043365
FCF margin (%): -14.47277083139333
Revenue growth (%): 3.921913626406496
Rule of 40 score: -10.550857204986833
Financial ratios for AVAV — quarterly report dated 2026-01-31
Total revenue: 408045000
Gross profit: 98794000
Operating income: -27732000
Net income: -243823000
Capital expenditures: 12597000
Operating cash flow: -5107000
Depreciation & amortization: 54633000
Net tangible assets: 884551000
Owner earnings: -201787000
Return on net tangible assets (%): -22.81236469123883
Buffett classification: The Gruesome
Stock price: 278.39
Shares outstanding: 50608030
Book value: 4272190000
P/B ratio: 3.2977862575634513
Market cap (USD): 14088769471.699999
Debt to equity: 0.19334650378377366
Current ratio: 5.509674478451049
Quick ratio: 4.5421393448187795
COGS to revenue (%): 75.78845470475069
R&D to revenue (%): 6.644365204818096
SG&A to revenue (%): 24.36348932103077
Free cash flow (dilution-adjusted): -29783000
Buyback yield (%): 0
Retained earnings: 33282000
Inventory turnover: 1.0333269846997932
Receivables turnover: 0.5281219827240323
Capitalized R&D asset: 62154930
ROCI (R&D-adjusted, %): -0.627930015556619
Rosenberg metric: -0.14755646931347763
FCF margin (%): -7.298949870725043
Revenue growth (%): -13.642731974908362
Rule of 40 score: -20.941681845633404
Financial ratios for AVON.L — annual report dated 2021-09-30
Total revenue: 335540540.5405405
Gross profit: 106486486.4864865
Operating income: -39189189.18918919
Net income: -34594594.5945946
Capital expenditures: 15810810.810810812
Operating cash flow: 10000000
Depreciation & amortization: 39729729.72972973
Net tangible assets: 32972972.972972974
Owner earnings: -10675675.675675683
Return on net tangible assets (%): -32.37704918032789
Buffett classification: The Gruesome
Stock price: 0.23540540540540544
Shares outstanding: 29451649
Book value: 277567567.5675676
P/B ratio: 0.02497798079746836
Market cap (USD): 6933077.372702704
Debt to equity: 0.34079844206426485
Current ratio: 2.713684210526316
Quick ratio: 1.4021052631578947
Interest coverage ratio: -4.833333333333333
COGS to revenue (%): 68.26419653644786
SG&A to revenue (%): 43.41522351993557
Free cash flow (dilution-adjusted): -33648648.64864865
Buyback yield (%): 0
Retained earnings: 156486486.4864865
Inventory turnover: 2.7207062600321024
Receivables turnover: 6.3020304568527905
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.257403189066059
FCF margin (%): -10.028191703584374
Rule of 40 score: -10.028191703584374
Financial ratios for AVON.L — annual report dated 2022-09-30
Total revenue: 292777777.7777778
Gross profit: 98777777.77777778
Operating income: 12222222.222222222
Net income: -8444444.444444444
Capital expenditures: 3222222.222222222
Operating cash flow: 31888888.888888888
Depreciation & amortization: 24222222.22222222
Net tangible assets: 43888888.88888889
Owner earnings: 12555555.555555554
Capex to operating income (%): 26.36363636363636
Buffett classification: The Good
Stock price: 0.11555555555555556
Shares outstanding: 29451649
Book value: 233888888.88888893
P/B ratio: 0.014550933472684085
Market cap (USD): 3403301.6622222224
Debt to equity: 0.3681710213776721
Current ratio: 2.337579617834395
Quick ratio: 0.9447983014861997
Effective tax rate (%): 5
Interest coverage ratio: 2.444444444444444
COGS to revenue (%): 66.2618595825427
R&D to revenue (%): 3.870967741935484
SG&A to revenue (%): 25.692599620493358
Free cash flow (dilution-adjusted): 20888888.888888888
Buyback yield (%): 404.8356315490831
Retained earnings: 133000000
Inventory turnover: 2.661585365853659
Receivables turnover: 10.095785440613028
Capitalized R&D asset: 11333333.333333334
ROCI (R&D-adjusted, %): 5.7216329154612655
FCF margin (%): 7.134724857685009
Revenue growth (%): -12.74443996957085
Rule of 40 score: -5.6097151118858415